Yazar "Ryoo, Baek-Yeol" seçeneğine göre listele
Listeleniyor 1 - 2 / 2
Sayfa Başına Sonuç
Sıralama seçenekleri
Öğe Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase 3 CELESTIAL trial.(Amer Soc Clinical Oncology, 2018) Abou-Alfa, Ghassan K.; Meyer, Tim; Cheng, Ann-Lii; El-Khoueiry, Anthony; Rimassa, Lorenza; Ryoo, Baek-Yeol; Cicin, Irfan[Abstract Not Available]Öğe Cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) who have received prior sorafenib: Results from the randomized phase III CELESTIAL trial.(Lippincott Williams & Wilkins, 2018) Abou-Alfa, Ghassan K.; Meyer, Tim; Cheng, Ann-Lii; El-Khoueiry, Anthony B.; Rimassa, Lorenza; Ryoo, Baek-Yeol; Cicin, Irfan[Abstract Not Available]
